Physician Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.16K Hold
22
– – ﹤0.01% 965
2026
Q2
$7.9K Buy
22
+6
+38% +$1.83K ﹤0.01% 939
2026
Q1
$4.01K Buy
16
+2
+14% +$498 ﹤0.01% 1086
2025
Q4
$3.85K Sell
14
-48
-77% -$13.1K ﹤0.01% 1061
2025
Q3
$16.3K Buy
62
+59
+1,967% +$14.3K ﹤0.01% 632
2025
Q2
$657 Sell
3
-2
-40% -$428 ﹤0.01% 1632
2025
Q1
$1.12K Buy
5
+3
+150% +$827 ﹤0.01% 998
2024
Q4
$656 Buy
+2
New +$629 ﹤0.01% 1064

Other funds holding WST

Physician Wealth Advisors's WST Position: Q3 2026 in Review

Physician Wealth Advisors held its West Pharmaceutical (WST) position steady in Q3 2026 at 22 shares worth $8.16K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Physician Wealth Advisors first reported a position in WST in Q4 2024 and has held it in 8 quarters since. The position peaked at $16.3K in Q3 2025. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Physician Wealth Advisors held 22 shares of West Pharmaceutical worth $8.16K as of Q3 2026.
  • Physician Wealth Advisors left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #965 holding.
  • Physician Wealth Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 8 quarters since.
  • Physician Wealth Advisors's West Pharmaceutical position peaked at $16.3K in Q3 2025.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.